Hygiene
Conditions
Brief summary
To demonstrate the safety and acceptability of the gynaecological formulation.
Interventions
DRUGLactic acid
Once a day
Sponsors
Sanofi
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Integral skin in the tested region
Exclusion criteria
* Pregnancy or breastfeeding women * Use of anti-inflammatory or immune-suppression drugs * Topical medication use at the tested region * Active cutaneous gynaecological disease which may interfere in study results * Personal history of allergic disease at the area to be treated * Allergic or atopic history The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical and local tolerability | After 21 days |
Countries
Mexico
Outcome results
None listed